Product Information
CHLORHEXIDINE 0.12% RINSE is a generic product labeled by Xttrium Laboratories, Inc., priced at $0.0168 per ML under NDC 00116200104. Its NADAC has been published 244 times since Jul 21, 2021.
FDA first approved this application on Jun 18, 2009. Its Orange Book therapeutic-equivalence code is AT.
Strength
1.2 mg/mL
Manufacturer
Xttrium Laboratories, Inc.NDC
00116200104
Classification
Generic
Dosage Form
RINSE
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
CHLORHEXIDINE GLUCONATEApproval Type
Generic (ANDA)
FDA Application
ANDA077789FDA Approved
6/18/2009
TE Code
AT
On Market Since
6/1/2010
Pharmacological Classes
Price Statistics
The NADAC for CHLORHEXIDINE 0.12% RINSE has been published 244 times since Jul 21, 2021, and over the history we have for it it has declined 22.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0168 per ML |
|---|---|
| All-time high | $0.0217 (Jul 13, 2022) |
| All-time low | $0.0146 (Aug 21, 2024) |
| 52-week high | $0.0168 |
| 52-week low | $0.0168 |
| Median price | $0.0168 |
| Average price | $0.0175 |
| Largest weekly change | -27.0% (Jul 20, 2022) |
| Weeks tracked | 244 |
| Tracking since | Jul 21, 2021 |
1W
N/A
1M
0.0%
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
+6.1%
5Y
-22.5%
All
-22.5%
Last surveyed Sep 16, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 56% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xttrium Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Chlorhexidine Gluconate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHLORHEXIDINE 0.12% RINSE?
The current National Average Drug Acquisition Cost (NADAC) for CHLORHEXIDINE 0.12% RINSE, manufactured by Xttrium Laboratories, Inc., is $0.0168 per ML (NDC 00116200104), effective Sep 16, 2026.
How has the price of CHLORHEXIDINE 0.12% RINSE changed over time?
Over the history we have for it, the NADAC for CHLORHEXIDINE 0.12% RINSE has declined 22.5%. It has been tracked across 244 weekly CMS publications since Jul 21, 2021.
What are the highest and lowest recorded NADAC prices for CHLORHEXIDINE 0.12% RINSE?
Since Jul 21, 2021, the NADAC for CHLORHEXIDINE 0.12% RINSE has ranged from a low of $0.0146 (Aug 21, 2024) to a high of $0.0217 (Jul 13, 2022), with a median of $0.0168 per ML.
Are there cheaper alternatives to CHLORHEXIDINE 0.12% RINSE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHLORHEXIDINE 0.12% RINSE, is $0.0073 per ML — about 56% below CHLORHEXIDINE 0.12% RINSE.
Who manufactures CHLORHEXIDINE 0.12% RINSE?
CHLORHEXIDINE 0.12% RINSE (NDC 00116200104) is labeled by Xttrium Laboratories, Inc., and CMS classifies it as a generic product.